Louisa Temme

Assistant Professor (Juniorprofessorin) of Pharmaceutical and Medicinal Chemistry

Universität Hamburg
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (5)

Year:

2026

Brachyury is a transcription factor that plays an essential role in tumour growth of the rare bone cancer chordoma and is implicated in other solid tumours. Brachyury is minimally expressed in healthy tissues, making it a potential therapeutic target. Unfortunately, as a ligandless transcription factor, brachyury has historically been considered undruggable. To investigate direct targeting of brachyury by small molecules, we determine the structure of human brachyury both alone and in complex with DNA. The structures provide insights into DNA binding and the context of the chordoma associated G177D variant. We use crystallographic fragment screening to identify hotspots on numerous pockets on the brachyury surface. Finally, we perform follow-up chemistry on fragment hits and describe the progression of a thiazole chemical series into binders with low µM potency. Thus we show that brachyury is ligandable and provide an example of how crystallographic fragment screening may be used to target protein classes that are difficult to address using other approaches.

Year:

2025

Background and Purpose Loss of function of the sperm‐specific Ca 2+ channel CatSper is a common channelopathy that causes male infertility. CatSper controls the intracellular Ca 2+ concentration and, thereby, the motility of human sperm. Activation of CatSper by oviductal ligands evokes a transient Ca 2+ increase, which entails changes in the flagellar beat that are required for fertilisation. The CatSper‐mediated Ca 2+ influx has been studied extensively, whereas the mechanisms underlying Ca 2+ clearance and recovery from Ca 2+ influx have remained ill‐defined. Experimental Approach We examined how pharmacological suppression of Ca 2+ export from the cytosol into the extracellular space or Ca 2+ uptake into intracellular stores affects the resting Ca 2+ concentration and CatSper‐mediated Ca 2+ signals in human sperm. We studied sperm of healthy volunteers and infertile men lacking functional CatSper channels, using kinetic Ca 2+ ‐ and pH‐fluorometry as well as patch‐clamp recordings. Key Results We show that Ca 2+ entering human sperm via CatSper is predominantly, if not exclusively, exported by plasma membrane Ca 2+ ATPases (PMCAs). Na + /Ca 2+ exchange and Ca 2+ uptake into intracellular stores or mitochondria play no or only a negligible role in Ca 2+ clearance in human sperm. Conclusions and Implications Ca 2+ signalling in human sperm is controlled by the functional interplay of CatSper and PMCAs, that is, the balance between Ca 2+ influx and Ca 2+ export that is required for human sperm function and fertilisation.

Year:

2025

Sperm activation is controlled by an influx of calcium ions through the CatSper channel, which is activated in the oviduct by a non-genomic action of progesterone. Progesterone has been hypothesized to act as an activator of ABHD2 activity, which in turn hydrolyses 1- and 2- arachadinoyl glycerol, putative inhibitors of CatSper. To explore the idea of targeting ABHD2 activity as a contraceptive target, we synthesized derivatives of published ABHD2 inhibitors, optimizing for potency and in-cell target engagement, and tested active inhibitors and structurally-related inactive derivatives in sperm motility assays and calcium influx assays. We observed no effect of ABHD2 inhibition on basal or progesterone-induced activity in both assays. We also found no evidence for direct binding of progesterone to purified recombinant ABHD2 protein. We conclude that ABHD2 activity is not required for the non-genomic action of progesterone on human sperm.

Year:

2024

Year:

2023

Collaborators (13)

Dalia Barsyte-Lovejoy

University of Toronto

CANADA
View details

Hans Oh

UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

UNITED STATES
View details

Martin Haraldsson

Senior Scientist

Karolinska Institutet

SWEDEN
View details

Evert Homan

Karolinska Institutet

SWEDEN
View details

Joseph A Newman

University of Oxford

UNITED KINGDOM
View details

Opher Gileadi

Head, Protein Sciences

Karolinska Institutet

SWEDEN
View details

Marc Spehr

Full Professor

RWTH Aachen University

GERMANY
View details

Johann Matschke

-

GERMANY
View details

Mohammad Anwar Hossain

Research Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Matthew Todd

Chair of Drug Discovery

University College London

UNITED KINGDOM
View details

Eve Carter

University College London

UNITED KINGDOM
View details

Paul Clarke

Team Leader

Institute of Cancer Research

UNITED KINGDOM
View details

Wenxin Felix Zhu

University of Münster

GERMANY
View details